BrightSpring Health Services, Inc. (BTSG) 株式分析

企業概要

BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform within the United States, delivering essential pharmacy and provider services through its clinical and operational infrastructure. The enterprise functions within the Healthcare sector, specifically categorized under Health Information Services, positioning it as a critical enabler for decentralized medical care delivery. In terms of scale, the company commands a market capitalization of $8.82B and generates annual revenue totaling $12.91B, while employing a workforce of 23,500 individuals. These financial metrics indicate a substantial enterprise with a significant revenue base that justifies its large market cap, suggesting a dominant position in the specialized healthcare services landscape.

財務健全性

The company reports a revenue of $12.91B for the trailing twelve months, with a net income of $106.35M and an EBITDA of $485.33M. The substantial disparity between the $12.91B revenue and the $106.35M net income reveals a cost structure where operating expenses consume a significant portion of gross receipts, leaving a relatively thin profit margin. Free cash flow stands at $-334,849,888, indicating a period of capital expenditure or investment that exceeds operating cash generation, which limits immediate financial flexibility for dividend payments or large-scale buybacks without external financing. Gross margin is recorded at 11.8%, reflecting the high cost of goods sold typical in healthcare services, while operating margin sits at 3.0% and profit margin at 1.5%, signaling that operational efficiencies are crucial for profitability in this low-margin industry. On the balance sheet, cash reserves of $88.37M are significantly lower than total debt of $2.71B, and the debt-to-equity ratio of 143.60% confirms that the capital structure is highly leveraged rather than conservative. The current ratio of 1.56 suggests the company maintains adequate liquidity to cover its short-term obligations, though the margin is not excessively high. Return on equity of 5.9% and return on assets of 3.3% indicate that management effectiveness in generating returns is moderate relative to the equity and asset bases employed.

バリュエーション評価

The valuation metrics show a trailing P/E ratio of 95.67 compared to a forward P/E of 23.49, implying that the market expects a dramatic increase in earnings per share over the coming year to justify the current high multiple. The price-to-book ratio of 4.99 indicates that the stock trades at a significant premium over its book value, reflecting investor confidence in future growth potential or intangible assets not captured on the balance sheet. Alternative valuation measures such as the price-to-sales ratio of 0.68 and an EV/EBITDA of 24.84 suggest that the company is valued based on revenue generation and enterprise cash flow, with the forward P/E implying a steep re-rating in earnings expectations. The 52-week high is recorded at $46.69 and the low at $15.48, meaning the current trading price sits within a wide historical range subject to market volatility. With a beta of 2.05, the stock exhibits high price volatility relative to the broader market, moving more than twice as much as the benchmark index in response to market swings.

Growth & Income

Revenue growth for the year over year is 29.3%, while earnings growth for the trailing twelve months is 338.3%, indicating that earnings are expanding at a rate significantly faster than revenue, likely driven by margin expansion or one-time income adjustments. As a non-dividend payer, the company maintains a dividend yield of N/A and a payout ratio of 0.0%, meaning it retains all earnings to fund operations, pay down debt, or reinvest into growth initiatives rather than distributing income to shareholders. The absence of a dividend program aligns with the company's high debt load and negative free cash flow, necessitating the retention of capital to maintain solvency and fund expansion. Overall, the growth and income profile is characterized by aggressive top-line expansion and earnings scaling, with no reliance on dividend income for shareholder returns.